Key result
Endovascular treatment linked to ~2.5-fold higher odds of favorable stroke recovery, regardless of renal function.
Why the study?
Whether renal insufficiency modifies the effectiveness and safety of endovascular treatment in patients with acute ischemic stroke and large infarct in a real-world setting was investigated.
Does endovascular treatment plus standard medical treatment improve 90-day favorable functional outcomes (modified Rankin scale 0–3) compared to standard medical treatment alone in patients with acute ischemic stroke and large infarct stratified by renal insufficiency status?
Cohort (n=745)
Yes
Does endovascular treatment plus standard medical treatment improve 90-day favorable functional outcomes (modified Rankin scale 0–3) compared to standard medical treatment alone in patients with acute ischemic stroke and large infarct stratified by renal insufficiency status?
In patients with acute ischemic stroke and large infarct, endovascular treatment improves 90-day functional outcomes despite a higher risk of symptomatic intracranial hemorrhage, regardless of baseline renal insufficiency status.
Answers are grounded in this paper and cite their sources.
May support endovascular treatment in large-infarct stroke irrespective of renal insufficiency; extends observational data but leaves open randomized confirmation.
Background This study aimed to investigate whether renal insufficiency (RI) modifies the effectiveness and safety of endovascular treatment (EVT) in patients with acute ischemic stroke and large infarct in a real‐world setting. Methods This study was a post hoc analysis of a prospective multicenter cohort study. RI was defined as an estimated glomerular filtration rate <90 mL/min per 1.73 m 2 on admission. Patients were treated with EVT plus standard medical treatment or standard medical treatment alone and were stratified by RI status. The primary effectiveness outcome was favorable outcome (modified Rankin scale 0–3) at 90 days. Safety outcomes included symptomatic intracranial hemorrhage and 90‐day mortality. Results Among 745 patients with acute ischemic stroke and large infarct, 343 (46.0%) had RI and 490 (65.8%) underwent EVT. Compared with standard medical treatment, EVT was associated with improved functional outcomes (modified Rankin scale 0–3) in both the RI (adjusted odds ratio [OR] 2.55 [95% CI, 1.15–5.68], P =0.022) and the non‐RI group (adjusted OR 2.65 [95% CI, 1.49–4.73], P =0.001). EVT was also associated with higher risks of symptomatic intracranial hemorrhage in both groups ( P =0.002 and 0.007, respectively), whereas no significant difference in mortality was observed. Results were consistent in the inverse probability‐weighted analyses. No statistically significant interaction was observed between RI status and treatment effect for effectiveness or safety outcomes. Conclusions In patients with acute ischemic stroke and large infarct, EVT was associated with improved functional outcomes but a higher risk of hemorrhagic complications. We did not find statistically significant evidence of interaction between EVT and RI status for 90‐day outcomes.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2026) conducted a cohort in Acute ischemic stroke with large infarct (n=745). Endovascular treatment (EVT) plus standard medical treatment vs. Standard medical treatment alone was evaluated on Favorable functional outcome (modified Rankin scale 0-3) at 90 days (OR 2.55, 95% CI 1.15-5.68, p=0.022). Endovascular treatment improved 90-day functional outcomes in stroke with large infarct both with and without renal insufficiency.
Synapse has enriched 10 related papers. Consider them for comparative context: